Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Dottikon ES Holding AG is a Swiss-based company specializing in the development and production of performance chemicals, primarily focusing on the pharmaceutical industry. The company is known for its hazardous reactions expertise, which supports its clients in drug development and production processes. Dottikon ES offers services and products including exclusive synthesis, process development, and related toll manufacturing. Headquartered in Dottikon, Switzerland, the company leverages its strategic positioning by focusing on safety, quality, and flexibility to meet specific customer needs in complex chemical reactions.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Dottikon ES Holding AGEli Lilly
Last price
CHF 257.50$1,142.85
Currency
CHF
USD
CHF 3.6B$1T
34.6338.36
CHF 7.49$29.79
0.940.50
0$6.69
00.61%
Sector
HealthHealth
Employees
90050,000
Ticker
Fr. DESN$LLY
Primary listing
XSWXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in Fr.DESN or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.